Inactive Instrument

Shandong Jintai Group Co., Ltd. Stock

Equities

600385

CNE0000018K3

Pharmaceuticals

Dynamic Chart
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shandong Jintai Group Co., Ltd. cancelled the transaction announced on March 4, 2021 CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Shandong Jintai Group Co., Ltd. Auditor Raises 'Going Concern' Doubt CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Shandong Jintai Group Co., Ltd. announced that it expects to receive CNY 155.956825 million in funding from Beijing Towercrest Investment Management Group Co., Ltd CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020 CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020 CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Shandong Jintai Group Co., Ltd. Provides Earnings Guidance for the Year 2019 CI
Shandong Jintai Group Co., Ltd. completed the acquisition of Jinan Jinda Pharmaceutical Chemical Co., Ltd. from Beijing Towercrest Investment Management Group Co., Ltd. CI
More news
Managers TitleAgeSince
Chief Executive Officer 53 07-07-19
Director of Finance/CFO 55 07-07-19
Director/Board Member 49 -
Members of the board TitleAgeSince
Director/Board Member 49 -
Chief Executive Officer 53 07-07-19
Director/Board Member 33 10-06-01
More insiders
SHANDONG JINTAI GROUP CO., LTD. is a China-based company primarily engaged in the trading business of gold jewelry products. In addition, the Comapany is also engaged in the manufacture of drugs. The Company distributes its products within domestic market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. 600385 Stock